Shineco (NASDAQ: SISI - Get Free Report) and Supernus Pharmaceuticals (NASDAQ: SUPN - Get Free Repor

Harrow (NASDAQ: HROW - Get Free Report) and Supernus Pharmaceuticals (NASDAQ: SUPN - Get Free Report

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,

ROCKVILLE, Md., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a

ROCKVILLE, Md., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Professional snowboarder, Chloe Kim, is partnering

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Supernus Pharmaceuticals

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale

BlackRock Inc. purchased a new position in Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the unde

Investors need to pay close attention to SUPN stock based on the movements in the options market lat

Supernus Pharmaceuticals (NASDAQ: SUPN - Get Free Report) and Vectura Group (OTCMKTS:VEGPF - Get Fre

Allworth Financial LP acquired a new position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ: S

INDV's proposed Supernus merger could broaden its CNS portfolio, cut costs and reduce reliance on Su

Supernus Pharmaceuticals (NASDAQ:SUPN) held its second-quarter earnings conference call on Tuesday.

Bank of America Corp DE lifted its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)

Assenagon Asset Management S.A. lessened its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ: SUP

California State Teachers Retirement System lifted its stake in Supernus Pharmaceuticals, Inc. (NASD

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan

Investors with an interest in Medical - Generic Drugs stocks have likely encountered both Supernus P

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swic

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

The most oversold health care stocks present a buying opportunity. RSI indicator compares stock stre

Supernus and Indivior agree to merge in an all-stock deal, targeting $2.2 billion in revenue and $12

Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly earnings of $0.53 per share which beat the

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 121.2% to $6.99 during Monday'

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) and Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) today

Cantor Fitzgerald analyst Kristen Kluska maintains Supernus Pharmaceuticals (NASDAQ:SUPN) with a

Supernus Pharmaceuticals (NASDAQ:SUPN) affirms FY2026 sales outlook from $840.000 million-$870.000 m

Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly losses of $(0.04) per share which missed t

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its

  On Tuesday, 647 companies set new 52-week lows.

  On Monday, 369 companies set new 52-week lows.

  During the session on Thursday, 461 stocks hit new 52-week lows.

  During Tuesday's session, 275 companies made new 52-week lows.

  Friday's session saw 169 companies set new 52-week lows.

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea